Cell line · CVCL_0346
IMR-32
Cancer cell line, Homo sapiens. Neuroblastoma. 94 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. IMR-32. Cell lines, record CVCL_0346. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0346
On this page
Cell line
As Cellosaurus gives it.
- Name
- IMR-32
- Accession
- CVCL_0346
- RRID
- RRID:CVCL_0346
- Synonyms
- IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 1Y1M
- Category
- Cancer cell line
- Diseases
- Neuroblastoma (NCIt C3270); Neuroblastoma (ORDO Orphanet_635)
- Derived from
- Abdomen (metastatic)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers94
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| RAS inhibition limits oncogenic signaling and tumorigenesis in neuroblastoma regardless of RAS mutational status | Sci Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Neuronal differentiation of neuroblastoma cell lines for neurological disease modeling. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Combined inhibition of PLK4 and PPM1D promotes cell death in cancer cells with 17q amplification. | Cancer Cell Int | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Multi‑omics identification of MSI2 as a super-enhancer‑driven vulnerability in MYCN‑amplified neuroblastoma. | J Transl Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The Host Cell Factor Phosphatase-2A Subunit PR130 Restricts Replication of Herpes Simplex Virus Type-1. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| QW-5-70 Targets the Colchicine Site and Demonstrates Antitumor Activity in P-gp-Overexpressing Cancer Models. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| DNA-PKcs promotes therapy resistance and metastatic recurrence in neuroblastoma. | Cancer Lett | 2026 | Its Methods give the RRID and name the line | PubMed | |
| YAP1 Enhances Mesenchymal-Type Gene Expression in Human Adrenergic-Type Neuroblastoma Cells. | Cancers (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Identification of CADM1 as an Immunotherapeutic Target and Evaluation of a Novel CADM1-Targeting Antibody-Drug Conjugate in Preclinical Osteosarcoma Models. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Defining the Functional Role and Potential as an Immunotherapeutic Target of ALCAM in Neuroblastoma. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 94
See all 94 papersRelatives29
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | I3.4.2 | CVCL_B0GV | Cell lines | |
| Derived from it | IMR-32 SimpleCell O-GalNAc | CVCL_S028 | Cell lines | |
| Derived from it | IMR-32/CMV-Luc | CVCL_A9J0 | Cell lines | |
| Derived from it | IMR-32_pCMV-DPP3 | CVCL_ER17 | Cell lines | |
| Derived from it | IMR-32_pCMV-SQSTM1 | CVCL_ER18 | Cell lines | |
| Derived from it | IMR-32rBORTE10 | CVCL_RS60 | Cell lines | |
| Derived from it | IMR-32rCARBO1000 | CVCL_ZX18 | Cell lines | |
| Derived from it | IMR-32rCARBO4000 | CVCL_RR66 | Cell lines | |
| Derived from it | IMR-32rCARBO5000 | CVCL_RS61 | Cell lines | |
| Derived from it | IMR-32rCDDP1000 | CVCL_RR67 | Cell lines |
1 to 10 of 29
See all 29 relativesCell banks19
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ABM | T8975 | ABM | |
| ATCC | CCL-127 | ATCC | |
| BCRC | 60014 | BCRC | |
| BCRJ | 0377 | BCRJ | |
| CCTCC | GDC0107 | Cellosaurus | |
| CLS | 300148 | CLS | |
| Coriell | AG03320 | Discontinued | Cellosaurus |
| Coriell | GM03320 | Coriell | |
| DSMZ | ACC-165 | DSMZ | |
| ECACC | 86041809 | ECACC |
1 to 10 of 19
See all 19 cell banksData dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0346
GET https://conductscience.org/api/cell-lines/v1/CVCL_0346/papers?page=2